Similar articles

• Inflammation and atherosclerosis--revisited.

  Pant S, Deshmukh A, Gurumurthy GS, Pothineni NV, Watts TE, Romeo F, Mehta JL. Pant S, et al. J Cardiovasc Pharmacol Ther. 2014 Mar;19(2):170-8. doi: 10.1177/1074248413504994. Epub 2013 Oct 31. J Cardiovasc Pharmacol Ther. 2014. PMID: 24177335 Review.
• Novel anti-inflammatory therapies for the treatment of atherosclerosis.

  Khan R, Spagnoli V, Tardif JC, L'Allier PL. Khan R, et al. Atherosclerosis. 2015 Jun;240(2):497-509. doi: 10.1016/j.atherosclerosis.2015.04.783. Epub 2015 Apr 18. Atherosclerosis. 2015. PMID: 25917947 Review.
• Inflammation and atherosclerosis: what is on the horizon?

  Ruparelia N, Choudhury R. Ruparelia N, et al. Heart. 2020 Jan;106(1):80-85. doi: 10.1136/heartjnl-2018-314230. Heart. 2020. PMID: 31843811 Review. No abstract available.
• Targeting the immune response in atherosclerosis: It's time for clinical trials!

  Joffre J, Ait-Oufella H. Joffre J, et al. Arch Cardiovasc Dis. 2017 Dec;110(12):643-645. doi: 10.1016/j.acvd.2017.08.001. Epub 2017 Oct 16. Arch Cardiovasc Dis. 2017. PMID: 29051009 No abstract available.
• Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.

  Kusters PJH, Lutgens E, Seijkens TTP. Kusters PJH, et al. Cardiovasc Res. 2018 Mar 1;114(3):368-377. doi: 10.1093/cvr/cvx248. Cardiovasc Res. 2018. PMID: 29309533 Review.